Clinical Trial

A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

Study acronym: D2570-202
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with moderately to severely active ulcerative colitis. A total of 120 subjects are planned to be included.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-16.
Status change: Recruiting → Active, Not Recruiting 2026-07-16
Trial Details
NCT Number NCT07035041
Lead Sponsor InventisBio Co., Ltd
Conditions UC - Ulcerative Colitis, Moderately to Severely Active Ulcerative Colitis
Enrollment 120 participants
Start Date 2025-05-22
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-17